Med-Mastodon

Bruno Amaral<a href="https://med-mastodon.com/@gregoryMS" class="u-url mention" rel="nofollow noopener" target="_blank">@gregoryMS</a> was having issues posting new <a href="https://mastodon.social/tags/papers" class="mention hashtag" rel="nofollow noopener" target="_blank">#papers</a> and <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> for <a href="https://mastodon.social/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#MultipleSclerosis</a>. It's working again! And have you seen the site lately? We made a lot of improvements and will have more coming. <a href="https://gregory-ms.com/" rel="nofollow noopener" translate="no" target="_blank">https://gregory-ms.com/</a> <a href="https://mastodon.social/tags/opensource" class="mention hashtag" rel="nofollow noopener" target="_blank">#opensource</a> <a href="https://mastodon.social/tags/ai" class="mention hashtag" rel="nofollow noopener" target="_blank">#ai</a> <a href="https://mastodon.social/tags/health" class="mention hashtag" rel="nofollow noopener" target="_blank">#health</a> <a href="https://mastodon.social/tags/research" class="mention hashtag" rel="nofollow noopener" target="_blank">#research</a> <a href="https://mastodon.social/tags/BotsFightMS" class="mention hashtag" rel="nofollow noopener" target="_blank">#BotsFightMS</a>

UK<a href="https://www.europesays.com/uk/251559/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/251559/</a> Two-faced gene variant appears good for men, bad for women <a href="https://pubeurope.com/tags/CincinnatiChildren" class="mention hashtag" rel="nofollow noopener" target="_blank">#CincinnatiChildren</a>'sHospitalMedicalCenter <a href="https://pubeurope.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>&MedicalDiscoveries <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/HealthCare" class="mention hashtag" rel="nofollow noopener" target="_blank">#HealthCare</a>&Hospitals <a href="https://pubeurope.com/tags/Pharmaceuticals" class="mention hashtag" rel="nofollow noopener" target="_blank">#Pharmaceuticals</a> <a href="https://pubeurope.com/tags/PollsAndResearch" class="mention hashtag" rel="nofollow noopener" target="_blank">#PollsAndResearch</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/surveys" class="mention hashtag" rel="nofollow noopener" target="_blank">#surveys</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

Matteo CesariRequest for Proposals: Policy Guidance for Better Access of Underrepresented Populations to Clinical Trials and Research.<a href="https://mastodon.social/tags/WHO" class="mention hashtag" rel="nofollow noopener" target="_blank">#WHO</a> <a href="https://mastodon.social/tags/OlderPeople" class="mention hashtag" rel="nofollow noopener" target="_blank">#OlderPeople</a> <a href="https://mastodon.social/tags/Aging" class="mention hashtag" rel="nofollow noopener" target="_blank">#Aging</a> <a href="https://mastodon.social/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#Research</a> <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon.social/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://mastodon.social/tags/Evidence" class="mention hashtag" rel="nofollow noopener" target="_blank">#Evidence</a>More info👇 <a href="https://www.ungm.org/Public/Notice/270860" rel="nofollow noopener" translate="no" target="_blank">https://www.ungm.org/Public/Notice/270860</a>

Bruno AmaralOur feed for <a href="https://mastodon.social/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#MultipleSclerosis</a> trials just got better <a href="https://gregory-ms.com/trials/" rel="nofollow noopener" translate="no" target="_blank">https://gregory-ms.com/trials/</a> It's updated in real time. <a href="https://mastodon.social/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/@gregoryMS" class="u-url mention" rel="nofollow noopener" target="_blank">@gregoryMS</a> <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>

Bruno AmaralIt's late here, but you know what is good? I just added a better search page to <a href="https://med-mastodon.com/@gregoryMS" class="u-url mention" rel="nofollow noopener" target="_blank">@gregoryMS</a> Now you can search over 35k <a href="https://mastodon.social/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener" target="_blank">#MultipleSclerosis</a> papers and more than 8k <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>.<a href="https://gregory-ms.com/search/" rel="nofollow noopener" translate="no" target="_blank">https://gregory-ms.com/search/</a> <a href="https://mastodon.social/tags/MSchat" class="mention hashtag" rel="nofollow noopener" target="_blank">#MSchat</a>

UK<a href="https://www.europesays.com/uk/203060/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/203060/</a> Treatment that is tailored just for you – Life News <a href="https://pubeurope.com/tags/BLKMaxSuperSpecialityHospital" class="mention hashtag" rel="nofollow noopener" target="_blank">#BLKMaxSuperSpecialityHospital</a> <a href="https://pubeurope.com/tags/CKBirlaHospital" class="mention hashtag" rel="nofollow noopener" target="_blank">#CKBirlaHospital</a> <a href="https://pubeurope.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://pubeurope.com/tags/CRISPRTechnology" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPRTechnology</a> <a href="https://pubeurope.com/tags/FortisMemorialResearchInstitute" class="mention hashtag" rel="nofollow noopener" target="_blank">#FortisMemorialResearchInstitute</a> <a href="https://pubeurope.com/tags/FutureOfMedicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#FutureOfMedicine</a> <a href="https://pubeurope.com/tags/GeneEditing" class="mention hashtag" rel="nofollow noopener" target="_blank">#GeneEditing</a> <a href="https://pubeurope.com/tags/GeneticDisorders" class="mention hashtag" rel="nofollow noopener" target="_blank">#GeneticDisorders</a> <a href="https://pubeurope.com/tags/GeneticTesting" class="mention hashtag" rel="nofollow noopener" target="_blank">#GeneticTesting</a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/HealthcareAccessibility" class="mention hashtag" rel="nofollow noopener" target="_blank">#HealthcareAccessibility</a> <a href="https://pubeurope.com/tags/HealthcareInnovation" class="mention hashtag" rel="nofollow noopener" target="_blank">#HealthcareInnovation</a> <a href="https://pubeurope.com/tags/MedicalAdvancements" class="mention hashtag" rel="nofollow noopener" target="_blank">#MedicalAdvancements</a> <a href="https://pubeurope.com/tags/MedicalResearch" class="mention hashtag" rel="nofollow noopener" target="_blank">#MedicalResearch</a> <a href="https://pubeurope.com/tags/PersonalizedMedicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#PersonalizedMedicine</a> <a href="https://pubeurope.com/tags/PrecisionOncology" class="mention hashtag" rel="nofollow noopener" target="_blank">#PrecisionOncology</a> <a href="https://pubeurope.com/tags/RareDiseases" class="mention hashtag" rel="nofollow noopener" target="_blank">#RareDiseases</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/TargetedTherapies" class="mention hashtag" rel="nofollow noopener" target="_blank">#TargetedTherapies</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

ResearchBuzz: FirehoseCIDRAP: Vaccine RCT spreadsheet aims to show the data, dispel myths about vaccines. “The project, led by Jake Scott, MD, is a spreadsheet of all the randomized controlled trials (RCTs) that have ever been conducted for licensed vaccines.”<a href="https://rbfirehose.com/2025/06/21/cidrap-vaccine-rct-spreadsheet-aims-to-show-the-data-dispel-myths-about-vaccines/" class="" rel="nofollow noopener" target="_blank">https://rbfirehose.com/2025/06/21/cidrap-vaccine-rct-spreadsheet-aims-to-show-the-data-dispel-myths-about-vaccines/</a>

Jan R. Boehnke<a href="https://mastodon.social/@statsepi" class="u-url mention" rel="nofollow noopener" target="_blank">@statsepi</a> Maybe of interest: <a href="https://mastodon.social/tags/Ireland" class="mention hashtag" rel="nofollow noopener" target="_blank">#Ireland</a> has established the National Clinical Trials Oversight Group to examine Ireland's clinical trials landscape to support better clinical outcomes through increasing the number of trials taking place and improving access to trials for participants: <a href="https://www.gov.ie/en/department-of-health/collections/national-clinical-trials-oversight-group/" rel="nofollow noopener" translate="no" target="_blank">https://www.gov.ie/en/department-of-health/collections/national-clinical-trials-oversight-group/</a><a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon.social/tags/RCT" class="mention hashtag" rel="nofollow noopener" target="_blank">#RCT</a>

Politico.eu (Unofficial RSS)Open drug pricing activist MSF signs secrecy pacts with Big Pharma <a href="https://www.politico.eu/article/open-drug-pricing-health-big-pharma-medicine-ngo-germany/?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication" rel="nofollow noopener" target="_blank">https://www.politico.eu/article/open-drug-pricing-health-big-pharma-medicine-ngo-germany/?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication</a> <a class="hashtag" href="https://social.espeweb.net/tag/clinicaltrials" rel="nofollow noopener" target="_blank">#Clinicaltrials</a> <a class="hashtag" href="https://social.espeweb.net/tag/negotiations" rel="nofollow noopener" target="_blank">#Negotiations</a> <a class="hashtag" href="https://social.espeweb.net/tag/transparency" rel="nofollow noopener" target="_blank">#Transparency</a> <a class="hashtag" href="https://social.espeweb.net/tag/drugpricing" rel="nofollow noopener" target="_blank">#Drugpricing</a> <a class="hashtag" href="https://social.espeweb.net/tag/healthcare" rel="nofollow noopener" target="_blank">#HealthCare</a> <a class="hashtag" href="https://social.espeweb.net/tag/companies" rel="nofollow noopener" target="_blank">#Companies</a> <a class="hashtag" href="https://social.espeweb.net/tag/exclusive" rel="nofollow noopener" target="_blank">#Exclusive</a> <a class="hashtag" href="https://social.espeweb.net/tag/medicines" rel="nofollow noopener" target="_blank">#Medicines</a> <a class="hashtag" href="https://social.espeweb.net/tag/patients" rel="nofollow noopener" target="_blank">#Patients</a> <a class="hashtag" href="https://social.espeweb.net/tag/doctors" rel="nofollow noopener" target="_blank">#Doctors</a> <a class="hashtag" href="https://social.espeweb.net/tag/patents" rel="nofollow noopener" target="_blank">#Patents</a> <a class="hashtag" href="https://social.espeweb.net/tag/pharma" rel="nofollow noopener" target="_blank">#Pharma</a> <a class="hashtag" href="https://social.espeweb.net/tag/ngos" rel="nofollow noopener" target="_blank">#NGOs</a>

Dominic TyerNHS App to offer clinical trial access in major digital health update<a href="https://www.htworld.co.uk/news/digital-health/nhs-app-to-offer-clinical-trial-access-in-major-digital-health-update-digi25/" rel="nofollow noopener" translate="no" target="_blank">https://www.htworld.co.uk/news/digital-health/nhs-app-to-offer-clinical-trial-access-in-major-digital-health-update-digi25/</a><a href="https://mas.to/tags/NHS" class="mention hashtag" rel="nofollow noopener" target="_blank">#NHS</a> <a href="https://mas.to/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>

Matteo CesariA global roadmap for inclusive clinical trials in older adults<a href="https://mastodon.social/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#Research</a> <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon.social/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://mastodon.social/tags/Ageing" class="mention hashtag" rel="nofollow noopener" target="_blank">#Ageing</a> <a href="https://mastodon.social/tags/Geriatrics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Geriatrics</a> <a href="https://mastodon.social/tags/Frailty" class="mention hashtag" rel="nofollow noopener" target="_blank">#Frailty</a> <a href="https://mastodon.social/tags/Aging" class="mention hashtag" rel="nofollow noopener" target="_blank">#Aging</a><a href="https://www.sciencedirect.com/science/article/pii/S1279770725001162" rel="nofollow noopener" translate="no" target="_blank">https://www.sciencedirect.com/science/article/pii/S1279770725001162</a>

Matteo CesariAdvancing the methodology of clinical trials for <a href="https://mastodon.social/tags/aging" class="mention hashtag" rel="nofollow noopener" target="_blank">#aging</a> populations: A call to <a href="https://mastodon.social/tags/innovation" class="mention hashtag" rel="nofollow noopener" target="_blank">#innovation</a>, <a href="https://mastodon.social/tags/inclusion" class="mention hashtag" rel="nofollow noopener" target="_blank">#inclusion</a>, and global relevance<a href="https://mastodon.social/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#Research</a> <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon.social/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://mastodon.social/tags/Ageing" class="mention hashtag" rel="nofollow noopener" target="_blank">#Ageing</a> <a href="https://mastodon.social/tags/Geriatrics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Geriatrics</a> <a href="https://mastodon.social/tags/Frailty" class="mention hashtag" rel="nofollow noopener" target="_blank">#Frailty</a><a href="https://www.sciencedirect.com/science/article/pii/S1279770725001125" rel="nofollow noopener" translate="no" target="_blank">https://www.sciencedirect.com/science/article/pii/S1279770725001125</a>

ASX Mkt. SensitiveClarity Pharmaceuticals ( <a href="https://mastodon-grafa.social/tags/CU6" class="mention hashtag" rel="nofollow noopener" target="_blank">#CU6</a> ) has released " First patient imaged in Phase III AMPLIFY trial " on Thu 29 May at 09:34 AEST <a href="https://mastodon-grafa.social/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedStates</a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener" target="_blank">#media</a> <a href="https://mastodon-grafa.social/tags/live" class="mention hashtag" rel="nofollow noopener" target="_blank">#live</a> <a href="https://grafa.com/asset/clarity-pharmaceuticals-ltd-6504-cu6.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cu6.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/clarity-pharmaceuticals-ltd-6504-cu6.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cu6.asx</a>

ASX Mkt. SensitiveNoxopharm ( <a href="https://mastodon-grafa.social/tags/NOX" class="mention hashtag" rel="nofollow noopener" target="_blank">#NOX</a> ) has released " Green light for HERACLES clinical trial " on Thu 29 May at 08:37 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener" target="_blank">#tax</a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener" target="_blank">#media</a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener" target="_blank">#ASX</a> <a href="https://grafa.com/asset/noxopharm-ltd-8713-nox.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nox.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/noxopharm-ltd-8713-nox.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nox.asx</a>

Tired CryptidHey folks in <a href="https://disabled.social/tags/Minnesota" class="mention hashtag" rel="nofollow noopener" target="_blank">#Minnesota</a>: If you live near the university, they're doing clinical trials on a treatment for Long COVID! (They're trialling Baricitinib, a JAK inhibitor) <a href="https://kstp.com/kstp-news/top-news/long-covid-patients-urged-to-enroll-in-u-of-m-clinical-trial/" rel="nofollow noopener" translate="no" target="_blank">https://kstp.com/kstp-news/top-news/long-covid-patients-urged-to-enroll-in-u-of-m-clinical-trial/</a> <a href="https://disabled.social/tags/LongCovid" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCovid</a> <a href="https://disabled.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>

ASX Mkt. SensitiveAvecho Biotechnology ( <a href="https://mastodon-grafa.social/tags/AVE" class="mention hashtag" rel="nofollow noopener" target="_blank">#AVE</a> ) has released " Receipt of R&D Tax Incentive " on Wed 28 May at 11:24 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener" target="_blank">#tax</a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener" target="_blank">#government</a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/News" class="mention hashtag" rel="nofollow noopener" target="_blank">#News</a> <a href="https://grafa.com/asset/avecho-biotechnology-ltd-5671-ave.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=ave.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/avecho-biotechnology-ltd-5671-ave.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=ave.asx</a>

ASX Mkt. SensitiveEmyria ( <a href="https://mastodon-grafa.social/tags/EMD" class="mention hashtag" rel="nofollow noopener" target="_blank">#EMD</a> ) has released " PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU " on Wed 28 May at 08:38 AEST <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener" target="_blank">#government</a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/News" class="mention hashtag" rel="nofollow noopener" target="_blank">#News</a> <a href="https://mastodon-grafa.social/tags/Strategy" class="mention hashtag" rel="nofollow noopener" target="_blank">#Strategy</a> <a href="https://grafa.com/asset/emyria-ltd-1695-emd.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=emd.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/emyria-ltd-1695-emd.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=emd.asx</a>

Innovative Health Initiative📢 Our May newsletter is now online! This month we're focusing on the value of <a href="https://mastodon.social/tags/PPPs" class="mention hashtag" rel="nofollow noopener" target="_blank">#PPPs</a> to address <a href="https://mastodon.social/tags/HealthChallenges" class="mention hashtag" rel="nofollow noopener" target="_blank">#HealthChallenges</a>. Discover: ✅ Draft texts for call 11 ✅ Info webinars on call 11 ✅ New project INTERCEPT ✅ Project results for <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a>, <a href="https://mastodon.social/tags/PaediatricResearch" class="mention hashtag" rel="nofollow noopener" target="_blank">#PaediatricResearch</a> and <a href="https://mastodon.social/tags/VaccineResearch" class="mention hashtag" rel="nofollow noopener" target="_blank">#VaccineResearch</a> 👉 <a href="https://europa.eu/!6mvTjP" rel="nofollow noopener" translate="no" target="_blank">https://europa.eu/!6mvTjP</a> <a href="https://mastodon.social/tags/IHITransformingHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#IHITransformingHealth</a> <a href="https://mastodon.social/tags/HealthResearch" class="mention hashtag" rel="nofollow noopener" target="_blank">#HealthResearch</a>

ASX Mkt. SensitivePYC Therapeutics ( <a href="https://mastodon-grafa.social/tags/PYC" class="mention hashtag" rel="nofollow noopener" target="_blank">#PYC</a> ) has released " Approval to Escalate Dosing in Kidney Disease Trial " on Mon 26 May at 09:13 AEST <a href="https://mastodon-grafa.social/tags/today" class="mention hashtag" rel="nofollow noopener" target="_blank">#today</a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#ClinicalTrials</a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#Australia</a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener" target="_blank">#media</a> <a href="https://mastodon-grafa.social/tags/live" class="mention hashtag" rel="nofollow noopener" target="_blank">#live</a> <a href="https://grafa.com/asset/pyc-therapeutics-ltd-3821-pyc.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=pyc.asx" rel="nofollow noopener" translate="no" target="_blank">https://grafa.com/asset/pyc-therapeutics-ltd-3821-pyc.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=pyc.asx</a>

Recent searches

Search options

Administered by:

Server stats:

#clinicaltrials